Conantokin G, Conantokin G inhibits NMDA receptors
- Known as:
- Conantokin G, Conantokin G inhibits NMDA receptors
- Catalog number:
- 08CON009-01000
- Product Quantity:
- 1000 ug
- Category:
- -
- Supplier:
- Smartox
- Gene target:
- Conantokin inhibits NMDA receptors
Related genes to: Conantokin G, Conantokin G inhibits NMDA receptors
- Gene:
- GRIN1 NIH gene
- Name:
- glutamate ionotropic receptor NMDA type subunit 1
- Previous symbol:
- NMDAR1
- Synonyms:
- GluN1
- Chromosome:
- 9q34.3
- Locus Type:
- gene with protein product
- Date approved:
- 1992-09-18
- Date modifiied:
- 2016-02-05
- Gene:
- GRIN2A NIH gene
- Name:
- glutamate ionotropic receptor NMDA type subunit 2A
- Previous symbol:
- NMDAR2A
- Synonyms:
- GluN2A
- Chromosome:
- 16p13.2
- Locus Type:
- gene with protein product
- Date approved:
- 1992-09-18
- Date modifiied:
- 2016-02-05
- Gene:
- GRIN2B NIH gene
- Name:
- glutamate ionotropic receptor NMDA type subunit 2B
- Previous symbol:
- NMDAR2B
- Synonyms:
- GluN2B
- Chromosome:
- 12p13.1
- Locus Type:
- gene with protein product
- Date approved:
- 1992-09-18
- Date modifiied:
- 2016-02-05
- Gene:
- GRIN2C NIH gene
- Name:
- glutamate ionotropic receptor NMDA type subunit 2C
- Previous symbol:
- NMDAR2C
- Synonyms:
- GluN2C
- Chromosome:
- 17q25.1
- Locus Type:
- gene with protein product
- Date approved:
- 1992-09-18
- Date modifiied:
- 2016-02-05
- Gene:
- GRIN2D NIH gene
- Name:
- glutamate ionotropic receptor NMDA type subunit 2D
- Previous symbol:
- NMDAR2D
- Synonyms:
- GluN2D, EB11, NR2D
- Chromosome:
- 19q13.33
- Locus Type:
- gene with protein product
- Date approved:
- 1993-07-29
- Date modifiied:
- 2016-02-05
Related products to: Conantokin G, Conantokin G inhibits NMDA receptors
*Please allow 3-5 days for delivery time.* Toll-like receptors (TLRs) play an essential role in the detection and elimination of invading pathogens. Recognition of microbial components by TLRs triggerABT-888 Veliparib (ABT-888) is a potential anti-cancer drug acting as a PARP inhibitor.It inhibits both PARP1 and PARP2. For research use only.Activin receptors are all transmembrane proteins, composed of a ligand-binding extracellular domain with cysteine-rich region, a transmembrane domain, and a cytoplasmic domain with predicted serine_thActivin receptors are all transmembrane proteins, composed of a ligand-binding extracellular domain with cysteine-rich region, a transmembrane domain, and a cytoplasmic domain with predicted serine_thADWX-1, ADWX-1 inhibits Kv1.3 channel with an IC50 of 1.89 pMADWX-1, ADWX-1 inhibits Kv1.3 channel with an IC50 of 1.89 pMADWX-1, ADWX-1 inhibits Kv1.3 channel with an IC50 of 1.89 pMANP32E inhibits activity of protein phosphatase 2A (PP2A). It does not inhibit protein phosphatase 1. It may play a role in cerebellar development and synaptogenesis process by modulating PP2A activitANP32E inhibits activity of protein phosphatase 2A (PP2A). It does not inhibit protein phosphatase 1. It may play a role in cerebellar development and synaptogenesis process by modulating PP2A activitAnti-acetylcholine nicotinic receptors Monoclonal AntibodyAnti-acetylcholine nicotinic receptors Monoclonal AntibodyAnti-Glutamate NMDA Receptor NR3A B Subunit MonoclonalAnti-Glutamate NMDA Receptor NR3A_B SubunitAnti-human trK A_trK B receptors (monoclonal)anti-NMDA Receptor 2A, affinity purified antibody, 100 ul.